search
Back to results

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

Primary Purpose

Atrial Fibrillation, Hemostasis

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Vascular closure with LockeT device
Sponsored by
Kansas City Heart Rhythm Research Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Atrial Fibrillation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Must be at least 18 years of age Be able to provide consent Presenting for planned procedures that require percutaneous venous punctures, such as atrial fibrillation radiofrequency ablation, and where the physician utilizes a LockeT device or MC to close the wound. Exclusion Criteria: Under the age of 18 Unable to or unwilling to provide consent Cannot comply with study requirements Not undergoing procedures that require a percutaneous venous puncture or planned access to the left atrium and/or ventricle Subjects whose physician does not use LockeT or MC to close the venous puncture. Patient is currently pregnant, as evidenced by positive urine Beta-HCG. (Urine Beta Human chorionic gonadotropin (HCG) will be checked in all females of the reproductive age group). If the physician detects a formed hematoma prior to venous closure, that patient will be excluded from the study.

Sites / Locations

  • Kansas City Heart Rhythm Institute - Roe ClinicRecruiting
  • Overland Park Regional Medical CenterRecruiting
  • Centerpoint Medical Center ClinicRecruiting
  • Centerpoint Medical CenterRecruiting
  • Research Medical Center ClinicRecruiting
  • Research Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

LockeT

Manual compression

Arm Description

These are the patients assigned for LockeT device arm to close the access site wound.

These are the patients assigned for Manual Compression arm to close the access site wound.

Outcomes

Primary Outcome Measures

Effectiveness of using the LockeT suture retention device
Effectiveness of using the LockeT suture retention device to gain hemostasis after venous procedures as compared to standard Manual Compression (MC) will be assessed.

Secondary Outcome Measures

Patient, physician, and nursing staff benefits
Patient, physician, and nursing staff benefits of the LockeT device will be assessed via LockeT device questionnaire with a scale of 1 to 5, 1 strongly disagree and 5 strongly agree.
Patient discomfort with Locket device
Pain discomfort will be assessed via Locket device questionnaire with a scale of 1 to 5, 1 strongly disagree and 5 strongly agree.
Incidence of hematoma/ecchymosis
The incidence of hematoma/ecchymosis post-procedure will be assessed.
Safety of LockeT device
Safety of LockeT device will be assessed by the incidence of adverse events, including but not limited to: vascular complications, like atrioventricular (AV) fistula, retroperitoneal bleed, surgical exploration of the groin (thrombin injection, open surgery or ligation); need for blood transfusion, defined as a 2 gm post-procedure drop in hemoglobin, or symptoms of anemia,).
Comparison of Manual Compression labor cost and Locket device cost
Manual Compression labor cost and Locket device cost will be compared

Full Information

First Posted
September 21, 2023
Last Updated
October 3, 2023
Sponsor
Kansas City Heart Rhythm Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT06078735
Brief Title
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
Official Title
Vascular Closure With Novel Ergonomic External Compression Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 2, 2023 (Actual)
Primary Completion Date
December 2024 (Anticipated)
Study Completion Date
December 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kansas City Heart Rhythm Research Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.
Detailed Description
The volume of catheter ablation procedures for the treatment of atrial fibrillation and other arrhythmias are on the rise in the United States and worldwide. Despite decrease in complication rates due to refinement in ablation tools and techniques, achieving vascular hemostasis following large-bore sheath femoral access remains a challenge. Thus, MC remains the current standard of care. However, MC requires up to 8 hours of prolonged bedrest, which is associated with longer length of stay and complications from indwelling catheters. Another method of vascular closure is the figure-of-eight (FoE) stitch - a subcutaneous suture that has been evaluated to achieve homeostasis following major cardiovascular procedures. In recent years, invasive, vascular closure devices have become popular. However, results continue to suggest that the risk versus benefit has not been definitively demonstrated. Instead, the LockeT is a new suture retention device designed to closely mimic manual compression by distributing the tension of a FoE stitch over a larger surface area. In such a way, patients can have the benefits of MC without a healthcare professional to stand bedside.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Hemostasis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized 1:1 to LockeT device or Manual Compression.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
110 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
LockeT
Arm Type
Experimental
Arm Description
These are the patients assigned for LockeT device arm to close the access site wound.
Arm Title
Manual compression
Arm Type
No Intervention
Arm Description
These are the patients assigned for Manual Compression arm to close the access site wound.
Intervention Type
Device
Intervention Name(s)
Vascular closure with LockeT device
Intervention Description
For subjects that are assigned to the LockeT device arm, the healthcare professional will place the LockeT with suture above the wound to achieve compression instead of manually holding pressure on the sutures. After hemostasis is achieved and prior to ambulation the LockeT will be removed followed by suture removal.
Primary Outcome Measure Information:
Title
Effectiveness of using the LockeT suture retention device
Description
Effectiveness of using the LockeT suture retention device to gain hemostasis after venous procedures as compared to standard Manual Compression (MC) will be assessed.
Time Frame
2 Days
Secondary Outcome Measure Information:
Title
Patient, physician, and nursing staff benefits
Description
Patient, physician, and nursing staff benefits of the LockeT device will be assessed via LockeT device questionnaire with a scale of 1 to 5, 1 strongly disagree and 5 strongly agree.
Time Frame
2 Days
Title
Patient discomfort with Locket device
Description
Pain discomfort will be assessed via Locket device questionnaire with a scale of 1 to 5, 1 strongly disagree and 5 strongly agree.
Time Frame
2 Days
Title
Incidence of hematoma/ecchymosis
Description
The incidence of hematoma/ecchymosis post-procedure will be assessed.
Time Frame
2 Days
Title
Safety of LockeT device
Description
Safety of LockeT device will be assessed by the incidence of adverse events, including but not limited to: vascular complications, like atrioventricular (AV) fistula, retroperitoneal bleed, surgical exploration of the groin (thrombin injection, open surgery or ligation); need for blood transfusion, defined as a 2 gm post-procedure drop in hemoglobin, or symptoms of anemia,).
Time Frame
2 Days
Title
Comparison of Manual Compression labor cost and Locket device cost
Description
Manual Compression labor cost and Locket device cost will be compared
Time Frame
2 Days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Must be at least 18 years of age Be able to provide consent Presenting for planned procedures that require percutaneous venous punctures, such as atrial fibrillation radiofrequency ablation, and where the physician utilizes a LockeT device or MC to close the wound. Exclusion Criteria: Under the age of 18 Unable to or unwilling to provide consent Cannot comply with study requirements Not undergoing procedures that require a percutaneous venous puncture or planned access to the left atrium and/or ventricle Subjects whose physician does not use LockeT or MC to close the venous puncture. Patient is currently pregnant, as evidenced by positive urine Beta-HCG. (Urine Beta Human chorionic gonadotropin (HCG) will be checked in all females of the reproductive age group). If the physician detects a formed hematoma prior to venous closure, that patient will be excluded from the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Donita Atkins
Phone
816-651-1969
Email
Datkins@kchrf.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dhanunjaya Lakkireddy, MD
Organizational Affiliation
Kansas City Heart Rhythm Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kansas City Heart Rhythm Institute - Roe Clinic
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66211
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
Datkins@kchrf.com
First Name & Middle Initial & Last Name & Degree
Dhanunjaya Lakkireddy, MD
Facility Name
Overland Park Regional Medical Center
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66215
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
Datkins@kchrf.com
Facility Name
Centerpoint Medical Center Clinic
City
Independence
State/Province
Missouri
ZIP/Postal Code
64057
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
datkins@kchrf.com
Facility Name
Centerpoint Medical Center
City
Independence
State/Province
Missouri
ZIP/Postal Code
64057
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
datkins@kchrf.com
Facility Name
Research Medical Center Clinic
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64032
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
Datkins@kchrf.com
First Name & Middle Initial & Last Name & Degree
Naga Venkata K. Pothineni, MD
Facility Name
Research Medical Center
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64032
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Donita Atkins
Phone
816-651-1969
Email
Datkins@kchrf.com
First Name & Middle Initial & Last Name & Degree
Naga Venkata K. Pothineni, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
31971899
Citation
Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio DB, Horton R, Spear W, Bailey S, Bunch J, Musat D, O'Neill P, Compton S, Turakhia MP; AMBULATE Trial Investigators. Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial. JACC Clin Electrophysiol. 2020 Jan;6(1):111-124. doi: 10.1016/j.jacep.2019.08.013. Epub 2019 Oct 30.
Results Reference
background
PubMed Identifier
32638389
Citation
Mujer MT, Al-Abcha A, Flores J, Saleh Y, Robinson P. A comparison of figure-of-8-suture versus manual compression for venous access closure after cardiac procedures: An updated meta-analysis. Pacing Clin Electrophysiol. 2020 Aug;43(8):856-865. doi: 10.1111/pace.14008. Epub 2020 Jul 20.
Results Reference
background
PubMed Identifier
31001767
Citation
Atti V, Turagam MK, Garg J, Alratroot A, Abela GS, Rayamajhi S, Lakkireddy D. Efficacy and safety of figure-of-eight suture versus manual pressure for venous access closure: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2020 Apr;57(3):379-385. doi: 10.1007/s10840-019-00547-6. Epub 2019 Apr 18.
Results Reference
background
PubMed Identifier
32308550
Citation
Jensen CJ, Schnur M, Lask S, Attanasio P, Gotzmann M, Kara K, Hanefeld C, Mugge A, Wutzler A. Feasibility of the Figure-of-8-Suture as Venous Closure in Interventional Electrophysiology: One Strategy for All? Int J Med Sci. 2020 Apr 6;17(7):965-969. doi: 10.7150/ijms.42593. eCollection 2020.
Results Reference
background

Learn more about this trial

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

We'll reach out to this number within 24 hrs